idw – Informationsdienst Wissenschaft
Nachrichten, Termine, Experten
Nachrichten, Termine, Experten
Researchers at the Else Kröner Fresenius Center (EKFZ) for Digital Health at TUD Dresden University of Technology, in collaboration with partners from Germany, the UK and USA, have developed and validated an autonomous artificial intelligence (AI) agent capable of supporting clinical decision-making in oncology. The findings were published in the journal Nature Cancer. In the future, AI agents could assist healthcare professionals in navigating complex medical data and supporting informed, personalized treatment decisions for cancer patients.
Clinical decision-making in oncology is challenging and requires the analysis of various data types – from medical imaging and genetic information to patient records and treatment guidelines. To effectively support medical practice, AI models must be capable of processing multimodal data and have reasoning and problem-solving capabilities that resemble those of humans.
To build an autonomous AI agent for precision medicine, the researchers enhanced the large language model GPT-4 with several digital tools – including radiology report generation from MRI and CT scans, medical image analysis, prediction of genetic alterations directly from histopathology slides, and search functions across platforms such as PubMed, Google and OncoKB. To ensure that decisions were grounded in current medical knowledge, the model was given access to around 6,800 documents compiled from official oncology guidelines and clinical resources.
Autonomous AI agents successfully tested on realistic, simulated patient cases
The AI agent was evaluated on 20 real-world, simulated patient cases using a two-step process: First, the system selected appropriate tools, then it retrieved relevant medical information to guide its reasoning. The outputs were reviewed by human medical experts for accuracy, completeness, and correct citation of sources. The AI agent reached correct clinical conclusions in 91% of cases and accurately cited relevant oncology guidelines in over 75% of its responses. Importantly, the use of specialized tools and medical information retrieval significantly improved the model’s performance. As a result, so-called “hallucinations” – seemingly plausible but incorrect statements – were significantly reduced. This improvement is particularly important in the sensitive area of healthcare.
“AI tools are designed to support medical professionals, freeing up valuable time for patient care,” says Dyke Ferber, first author of the publication. “They could help in daily decision-making processes and support doctors to stay updated on the latest treatment recommendations, contributing to the identification of optimal personalized care for cancer patients.”
Potential future support in everyday clinical practice
The study serves as proof of principle that AI agents can be designed to support oncologists in everyday clinical practice. Despite the promising results, the researchers acknowledge current limitations of their study. The system was only tested on a small number of simulated cases and requires further validation. Future work will focus on integrating conversational capabilities with human feedback – so-called “human-in-the-loop” interactions – and ensuring data privacy through deployment on local servers.
“To fully leverage the potential of AI agents in the future, it will be crucial to integrate them smoothly into routine clinical practice with minimal disruption,” says Prof. Jakob N. Kather, Professor of Clinical Artificial Intelligence at EKFZ for Digital Health at TU Dresden, and oncologist at Dresden University Hospital Carl Gustav Carus. “Challenges such as interoperability with existing systems, compliance with data privacy laws, the need for regulatory approval processes as medical devices, and ensuring accountability still need to be addressed.”
Long-term, the research team envisions that similar AI agents could be adapted for use in other medical fields – provided they are equipped with appropriate tools and data. “For successful implementation of medical AI agents, medical professionals need to be well educated on how to effectively collaborate with these systems while maintaining full authority over final clinical decision-making”, Prof. Kather adds. “These agents are designed to support clinicians, but by no means to replace them.”
Overall, the study highlights the considerable potential of large language models when combined with precision oncology and search tools, establishing a solid foundation for the future use of AI-driven, personalized support systems in clinical practice.
Publication
Else Kröner Fresenius Center (EKFZ) for Digital Health
The EKFZ for Digital Health at TU Dresden and University Hospital Carl Gustav Carus Dresden was established in September 2019. It receives funding of around 40 million euros from the Else Kröner Fresenius Foundation for a period of ten years. The center focuses its research activities on innovative, medical and digital technologies at the direct interface with patients. The aim here is to fully exploit the potential of digitalization in medicine to significantly and sustainably improve healthcare, medical research and clinical practice.
Contact:
EKFZ for Digital Health
Anja Stübner and Dr. Viktoria Bosak
Public Relations
Tel.: +49 351 - 458 11379
Email: news.ekfz@tu-dresden.de
Dyke Ferber, Omar S. M. El Nahhas, Georg Wölflein, Isabella C. Wiest, Jan Clusmann, Marie-Elisabeth Leßmann, Sebastian Foersch, Jacqueline Lammert, Maximilian Tschochohei, Dirk Jäger, Manuel Salto-Tellez, Nikolaus Schultz, Daniel Truhn, Jakob Nikolas Kather: Development and validation of an autonomous artificial intelligence agent for clinical decision-making in oncology, Nature Cancer, 2025.
Link: https://www.nature.com/articles/s43018-025-00991-6
doi: https://doi.org/10.1038/s43018-025-00991-6
TUD-Researchers have developed and validated an autonomous artificial intelligence (AI) agent capabl ...
iStock / SurfUpVector
iStock / SurfUpVector
Merkmale dieser Pressemitteilung:
Journalisten, Wissenschaftler
Informationstechnik, Medizin
überregional
Forschungsergebnisse, Wissenschaftliche Publikationen
Englisch
TUD-Researchers have developed and validated an autonomous artificial intelligence (AI) agent capabl ...
iStock / SurfUpVector
iStock / SurfUpVector
Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.
Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).
Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.
Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).
Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).
